First Quadrant’s Avanos Medical AVNS Stock Holding History

First Quadrant’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,194	Closed	-$41K	–	172
2021 Q4	$41K	Buy	+1,194	New	+$38.6K	﹤0.01%	422
2019 Q1	–	Sell	-4,645	Closed	-$208K	–	711
2018 Q4	$208K	Buy	4,645 +104	+2%	+$5.45K	0.02%	531
2018 Q3	$311K	Buy	+4,541	New	+$292K	0.01%	571
2016 Q4	–	Sell	-175	Closed	-$6K	–	834
2016 Q3	$6K	Buy	175 +63	+56%	+$2.21K	﹤0.01%	851
2016 Q2	$4K	Sell	112 -500	-82%	-$15.3K	﹤0.01%	797
2016 Q1	$18K	Hold	612	–	–	﹤0.01%	729
2015 Q4	$20K	Hold	612	–	–	﹤0.01%	705
2015 Q3	$17K	Hold	612	–	–	﹤0.01%	743
2015 Q2	$25K	Hold	612	–	–	﹤0.01%	726
2015 Q1	$30K	Hold	612	–	–	﹤0.01%	685
2014 Q4	$28K	Buy	+612	New	+$24K	﹤0.01%	692

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Quadrant's AVNS Position: Q1 2022 in Review

First Quadrant sold out of Avanos Medical (AVNS) in Q1 2022, closing a stake of 1,194 shares — an estimated $41K sold.

First Quadrant first reported a position in AVNS in Q4 2014 and held it in 11 quarters. The position peaked at $311K in Q3 2018. 299 funds tracked by Wall St. Rank hold AVNS as of Q1 2022.

First Quadrant reported no remaining Avanos Medical position as of Q1 2022 after selling out during the quarter.
First Quadrant sold 1,194 Avanos Medical shares in Q1 2022, an estimated $41K.
First Quadrant first reported a position in Avanos Medical in Q4 2014 and held it in 11 quarters.
First Quadrant's Avanos Medical position peaked at $311K in Q3 2018.
299 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2022.

Based on First Quadrant's 13F filing for Q1 2022, filed 21 Apr 2022.